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Abstract.  In a previous study, osteosarcoma cells 
expressing both 5-1ipoxygenase (5-LO) and 5 lipoxy- 
genase-activating protein (FLAP) synthesized leuko- 
trienes upon A23187 stimulation (Dixon,  R. A.  E, 
R. E.  Diehl,  E. Opas,  E.  Rands, P. J.  Vickers, J.  E 
Evans, J. W.  Gillard,  and D. K.  Miller.  1990. Nature 
(Lond.).  343:282-284).  Osteosarcoma cells expressing 
5-LO but not expressing FLAP were unable to syn- 
thesize leukotrienes.  Thus,  it was determined that 
FLAP was required for the cellular synthesis of leuko- 
trienes.  To examine the role of FLAP in A23187- 
induced translocation of 5-LO to a membrane fraction, 
we have studied the A23187-stimulated translocation of 
5-LO in osteosarcoma cells expressing both 5-LO and 
FLAP, and in osteosarcoma cells expressing 5-LO 
only. We demonstrate that in cells expressing both 
5-LO and FLAP, 5-LO translocates to membranes in 
response to A23187 stimulation.  This 5-LO transloca- 
tion is inhibited when cells are stimulated in the pres- 
ence of MK-886. In osteosarcoma cells expressing 
5-LO but not expressing FLAP, 5-LO is able to as- 
sociate with membranes following A23187 stimulation. 
In contrast to the cells containing both 5-LO and 
FLAP, MK-886 is unable to prevent 5-LO membrane 
association in cells transfected with 5-LO alone. 
Therefore,  we have demonstrated that in this cell sys- 
tem, 5-LO membrane association and activation can 
be separated into at least two distinct steps:  (1) 
calcium-dependent movement of 5-LO to membranes 
without product formation,  which can occur in the ab- 
sence of FLAP (membrane association), and (2) acti- 
vation of 5-LO with product formation,  which is 
FLAP dependent and inhibited by MK-886 (enz  me 
activation). 
T 
HE enzyme 5-1ipoxygenase (5-LO) t is the first com- 
mitted enzyme in the biosynthetic pathway that leads 
to the production of leukotrienes (1-3). Leukotrienes, 
produced by inflammatory  cells, have potent biological  ef- 
fects, including leukocyte chemotaxis,  bronchoconstriction, 
vasoconstriction,  and increased  vascular  permeability (4). 
Because leukotrienes  have been implicated in a variety of in- 
flammatory diseases (5),  the regulation  of the synthesis of 
leukotrienes has been studied  extensively. 
5-LO has been purified, cloned, and expressed in mamma- 
lian cells (6-15).  The enzyme is a 78-kD cytosolic protein 
with an absolute requirement  for calcium and ATP for activ- 
ity. Upon stimulation of 5-LO expressing myeloid cells with 
the calcium ionophore A23187, 5-LO translocates  to a mem- 
brane  compartment  where it catalyzes the production of 
LTA4 from arachidonic  acid  (16-19).  A  quantitative  and 
temporal correlation of 5-LO translocation  with leukotriene 
synthesis was shown in human peripheral blood leukocytes 
after ionophore challenge (16). It has also been demonstrated 
that 5-LO translocates  to a membrane compartment in RBL- 
2H3 cells stimulated  by ionomycin or the tumor promoter 
1. Abbreviations used in this paper: 5-LO, 5 lipoxygenase;  cPLA2,  cyto- 
solic phospholipase A2; FLAP,  5  lipoxygenase-activafing  protein; GAP, 
GTPase activating protein; MBS, membrane binding site; NRS, preimmune 
serum; PKC C-2, constant region 2 of protein kinase C; TTBS,  TBS + 
0.05%  Tween 20. 
thapsigargin  (20).  In  addition,  two separate  studies  have 
shown translocation  of 5-LO to a membrane fraction  in re- 
sponse to receptor-mediated stimuli,  namely fMLP (18) and 
antigen (21). In RBL-2H3 cells,  it was shown that ionomy- 
cin and  thapsigargin  induced  LTC4 production  and  5-LO 
translocation  primarily by causing an influx of extracellular 
calcium (20).  Two distinct  classes of leukotriene synthesis 
inhibitors have been shown to selectively inhibit the A23187- 
and fMLP-induced  translocation  of 5-LO to the membrane 
(18, 22). These inhibitors  have also been shown to interact 
specifically with the 18-kD membrane protein,  FLAP (23). 
FLAP inhibitors have been shown to inhibit leukotriene  syn- 
thesis in all cells that make leukotrienes and a correlation has 
been shown between FLAP inhibitors' potency for inhibition 
of leukotriene synthesis  and  degree of inhibition  of 5-LO 
translocation  (22). MK-886 has also been shown not only to 
prevent 5-LO translocation  but also to reverse the transloca- 
tion process (22). 
To investigate the role of FLAP in leukotriene synthesis, 
5-LO and FLAP were expressed in osteosarcoma cells (24). 
Wild-type osteosarcoma cells or cells  expressing  human 
5-LO did not synthesize leukotrienes in response to stimula- 
tion with A23187. In contrast, cells expressing  both 5-LO 
and FLAP synthesized leukotrienes after A23187 activation. 
This leukotriene production was inhibition by the compound 
MK-886 that binds selectively to FLAP (24). These studies 
￿9  The Rockefeller University Press, 0021-9525/92/12/1701/9 $2.00 
The Journal of Cell Biology, Volume 119, Number 6, December 1992 1701-1709  1701 verified that FLAP is essential for leukotriene synthesis but 
did not define the mechanism by which FLAP activates 5-LO 
in osteosarcoma cells. 
We  utilized  the  osteosarcoma  cell  system  to  examine 
whether FLAP was essential for the membrane association 
of 5-LO. In the following paper,  we show that 5-LO translo- 
cates to a membrane compartment in A23187-stimulated os- 
teosarcoma cells expressing FLAP. This translocation is in- 
hibited by MK-886, yet is not inhibited by the structurally 
similar indole, L-583,916 which is inactive as a leukotriene 
synthesis inhibitor. Unexpectedly, 5-LO also associates with 
membranes in A23187-stimulated cells not expressing FLAP. 
In contrast to cells expressing both 5-LO and FLAP,  5-LO 
membrane association was not inhibited by MK-886 in cells 
not expressing FLAP. The present experiments suggest that 
5-LO translocation and activation can be considered to occur 
in at least two steps:  (/) movement to membranes without 
product formation, followed by (2) enzyme activation result- 
ing in product formation. Our results suggest that the first 
step (membrane association) is calcium dependent and can 
occur in cells  lacking  FLAP,  but is  inhibited by MK-886 
when FLAP is present. In contrast, step 2 has an absolute 
requirement for FLAP and is inhibited by MK-886. We pro- 
pose  two possible  models  to suggest how this may  occur 
within the cell. The first model does not require a direct in- 
teraction of 5-LO and FLAP,  whereas the second model is 
based on a direct protein-protein interaction. Both models 
predict localization of 5-LO and FLAP in the same mem- 
brane compartment after A23187 challenge. All of the 5-LO 
translocation studies to date in various cell types (rat PMN, 
RBL-1  cells,  RBL-2H3 cells,  MeaSO-differentiated  HL-60 
cells, human peripheral blood leukocytes and transfected hu- 
man osteosarcoma cells) and with various stimuli (A23187, 
ionomycin, thapsigargin, and antigen) are consistent with ei- 
ther of these models. 
Materials and Methods 
Cell Culture 
Human osteosareoma cells transfected with human 5-LO eDNA have been 
previously described (13). These cells were grown in Dulbecco's modified 
Eagle's  medium  supplemented with  10%  heat  inactivated FBS  (Sigma 
Chemical Co., St. Louis, MO), 50 U/mi penicillin, 50 #g/ml streptomycin 
(Flow Laboratories, McLean, VA), 2 mM glutamine (Flow Laboratories), 
25 mM Hepes, pH 7.4,  1.1 mg/liter sodium pyruvate (Flow Laboratories), 
and 2OO #g/liter Gentamicin (Sigma Chemical Co.) at 37~  under an at- 
mosphere of 5 % CO2.  Because the expression vector for 5-LO contains 
the hygromycin resistance gene, 300 #g/ml hygromycin B  (Calbiochem 
Corp., La Jolla, CA) was added to media. Cell lines transfected with the 
expression vector for rat FLAP contained the neomycin resistance gene as 
previously described (24). These cells also contained the 5-LO construct 
indicated above and were passaged in the same medium in the presence of 
both 3OO #g/m1 hygromycin B and 400 #g/ml G418 (Gibeo Laboratories, 
Grand  Island,  NY,  or  Sigma  Chemical  Co.).  Cells  were  grown  in 
monolayers on 225 cm  2 or 600 cm  2 dishes (NUNC, Naperville, IL). 
Leukotriene Synthesis 
Monolayers of osteosarcoma cells were rinsed with Dulbecco's phosphate 
buffered saline (dPBS).  1 mM stocks of MK-886 or L-583,916 were pre- 
pared in Me2SO.  Cells were preincubated by overlaying the monolayer 
with 2.5 or 6.5 ml (225 or 600 cm  2 plates, respectively) of dPBS contain- 
ing 2 #M drug or Me2SO as control for 5 rain at 37~  Cells were stimu- 
lated by adding an equal volume of dPBS containing 2  #M A23187  in 
Me2SO for 10 rain at 37~  The final concentrations of drng and A23187 
were 1 #M. The liquid above the cell monolayer was removed and combined 
with an equal volume of 0.1 umol/ml prostaglandin Dz (PGB2) in ice cold 
methanol. Samples were acidified by addition of 10 #1 of concentrated for- 
mic acid per ml of aqueous solution, extracted with chloroform and ana- 
lyzed by reverse phase HPLC on a Waters C18 Novapak column, as previ- 
ously described (17). Approximately 80-85 % of the ieukotrienes produced 
by these cells is secreted into the medium (data not shown). Leukotrienes 
were eluted with acetonitrile:methanol:water:acetic acid (28:18:54:1)  pH 
5.6  at  a  flow  rate  of  1.2  ml/min,  monitoring  absorbance at  270  urn. 
Identified products  were  6-trans-LTB4,  6-trans-12-epi-LTB4 and  LTB4, 
with approximate elution times of 17, 19, and 22 min, respectively. Under 
these conditions, PGB2 eluted at 11 rain. Leukotriene production was de- 
termined by comparison with the PGB2 internal standard, correcting for 
the relative absorption maxima of the products. 
Homogenization of Cells and Preparation of 
Supernatants and Pellets 
Immediately after stimulation of the cells and removal of the liquid above 
the cell monolayer, the cells were removed by scraping with a rubber spatula 
and pelleted at 1,OO0 g for 10 min at room temperature. Cell pellets were 
resuspended in homogenization buffer (50 mM potassium phosphate buffer, 
pH 7.1, 0.1  M  NaC1,  2  mM EDTA,  1 mM dithiothreitol, 0.5 mM phe- 
nylmethylsulfonyl fluoride, and 60 #g/ml soybean trypsin inhibitor) and 
disrupted by sonication as described previously (17).  The samples were 
centrifuged at  10,0OO g  for  15  rain at 4~  The  10,0OO g  supernatants 
were further centrifuged at  1OO,OO0 g  for 45 min at 4~  The resulting 
100,000 g supernatants (100S) were collected; the 1OO,OO0  g pellets (looP) 
were rinsed twice with KPB-2 (20 mM potassium phosphate buffer, pH 7.1 
containing 2 mM EDTA and 1 mM dithiothreitol) and then resuspended in 
one fifth the original volume KPB-2 using a Potter-Elvehjem homogenizer. 
Broken Cell Assay of  S-LO Activity 
5-LO activity was determined in 1-ml reaction volumes containing 0.1 mM 
arachidonic acid,  2  #M  15-hydroperoxy-ll,13-eicosadienoic acid, 0.1  M 
Tris-HC1,  3 mM CaCI2,  2 mM ATP, 1 mM dithiothreitol, 2.5% glycerol, 
30 mM potassium phosphate, and '~1.5 mg 100S or 100P protein, at a final 
pH of 7.5. The reaction mixture was incubated for 10 rain at 37~  and the 
reaction was then terminated by addition of 1 ml of  ice-cold ethanol contain- 
ing ,'o2.5 nmol/ml 13-hydroxylinoleic acid as internal standard. Protein was 
precipitated by centrifugation at 14,000 g in an eppendorf  microfuge for 10 
min at 4~  Aliquots (200 #1) of the resulting supernatant were analyzed 
by reverse phase HPLC as described previously (17).  Under these condi- 
tions,  the  major  5-LO  products  are  5-HETE  and  5-HPETE,  which 
cochromatograph in our HPLC conditions. Activity is expressed as nmol 
5-HETE/10  s cells/10 rain reaction. Similar results were obtained if activity 
is expressed as nmol 5-HETE/mg protein/10 rain reaction. 
SDS-PAGE and Immunoblot Analysis of  5-LO 
Immediately following the preparation of IOOS and 100P samples, aliquots 
were mixed with 0.5-vol SDS sample buffer [20 mM Tris-HCl, pH 6.8, con- 
taining 0.4% (w/v) SDS, 4% glycerol, 0.24 M/3-mercaptoethanol, and a 
trace of bromophenol blue], boiled for 5 rain and subjected to SDS-PAGE 
on 9  x  10 cm precast 10 % Tris-glycine acrylamide gels (Novex, Novel Ex- 
perimental  Technology,  San  Diego,  CA)  according  to  the  method  of 
Laemmli (25). Proteins were electrophoretically transferred to nitrocellu- 
lose membranes as described previously (26). After transfer, nonspecific 
sites on the membrane were blocked with 3 % gelatin in TBS (20 mM Tris- 
HCI, pH 7.5, 0.5 M NaC1) for 20-30 min at room temperature, and then 
the membranes were washed two times in TTBS (TBS +  0.05% Tween 20) 
for 5 rain each. Blots were then incubated with a 1:200 final dilution LO32 
rabbit polyclonal antiserum to purified human leukocyte 5-LO in 1% gelatin 
in TTBS for 2-3 h at room temperature. After washing the blot twice in 
TTBS,  membranes were incubated with 5  ￿  105 cpm/ml L25I-protein A 
(low specific activity,  Du Pont-New England Nuclear) for 45 rain in 1% 
gelatin in TTBS.  The blots were washed five times in 50-ram potassium 
phosphate buffer,  pH 7.1, 0.1 M NaCI, 0.5% Triton X-100 and exposed to 
XAR-5 film at -70~  for ~24 h. Autoradiographs were scanned using an 
LKB 2202 Ultrascan laser densitometer, and the area under the peak corre- 
sponding to the 5-LO band was used to compare relative amounts of 5-LO 
protein. For all conditions six to nine lanes were scanned representing two 
to three separate experiments with duplicate cell aliquots. Data is expressed 
as means +SE. It has been shown previously by titration of purified human 
5-LO into leukocyte cytosolic fractions that a linear response to increasing 
amounts of 5-LO can be detected by immunoblot analysis (16). 
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100P samples from osteosarcoma cells expressing 5-LO only or 5-LO and 
FLAP were combined with 0.5 vol SDS sample buffer and subjected to 
SDS-PAGE on 9  ￿  10 cm precast 8-16% gradient Tris-glycine gels (Novex) 
according to the method of Laemmli (25). Immunoblot  analysis was per- 
formed essentially as described above, except that blots were incubated with 
a 1:200 final dilution of preimmune serum (NRS) or H5 antiserum. H5 is 
a  rabbit polyclonal antipeptide antibody which recognizes amino acid 
residues 41-52 of human FLAP. 
Photoa~inity Labeling and Immunoprecipitation 
Photoaffinity labeling and immunoprecipitation was performed as previ- 
ously  described  using  the quindole  photoatiinity  ligand  [125I]L-691,678 
(27).  Immunoprecipitation of photoafl~nity-labeled FLAP was performed 
with H5 antiserum according to previously described procedures (28). 
Statistical Analysis 
All data was subjected to statistical analysis using the Student's independent 
t  test (SigmaPlot 4.1;  Jandel  Scientific,  Corte  Madera,  CA).  Statistical 
significance was determined as the differences in responses between control 
versus challenged  cells, and for cells challenged  in the absence and presence 
of drug. An * denotes P < 0.05  %, ** denotes P < 0.01, and *** denotes 
P < 0.005. 
Results 
Synthesis of Leukotrienes in A23187-Stimulated 
Osteosarcoma  Cells Expressing 5-LO and FLAP 
Osteosarcoma cells expressing 5-LO and FLAP synthesized 
undetectable levels of leukotrienes in the absence of stimula- 
tion with A23187  (Fig.  1 A).  In agreement with previous 
findings (24), cells stimulated with 1 #M A23187 synthesize 
LTB4,  and the nonenzymatic hydrolysis products of LTA4, 
namely, 6-trans LTB4 and 6-trans-12-epi LTB4 (Fig.  1 B). 
These products were identified by elution position and stan- 
dard ultra violet spectra identifying absorption maxima at 
260, 270, and 280 nm. When cells were preincubated in the 
presence  of  1  tiM  MK-886,  A23187-induced  leukotriene 
production was completely inhibited (Fig.  1 C). In contrast 
to cells  preincubated  with  MK-886,  leukotriene  synthesis 
was not inhibited  in cells  preincubated  with  L-583,916,  a 
compound structurally related to MK-886 but which does 
not inhibit leukotriene synthesis in HL-60 cells (19) (Fig.  1 
D).  We were unable to detect any leukotrienes  in A23187- 
stimulated osteosarcoma cells expressing 5-LO only (data 
not shown). 
Characterization of  FLAP in Osteosarcoma Cells 
Expressing 5-LO and FLAP 
We wanted to verify that the osteosarcoma cells used in these 
experiments, transfected with both 5-LO and FLAP cDNAs, 
expressed full-length FLAP which was able to bind MK-886 
analogs.  100,000 g  pellets were prepared  from these cells 
and analyzed for the presence of FLAP by immunoblot anal- 
ysis  and  by  photoatfinity  labeling  experiments.  Fig.  2  A 
shows that FLAP can be detected in the membrane fraction 
of these cells by immunoblot analysis using an antipeptide 
antisera to FLAE In earlier studies in sonicated rat PMN, 
we have shown FLAP can be found in all membrane frac- 
tions following differential centrifugation (J.  Evans, unpub- 
lished data). However the highest concentration of FLAP is 
found in 100,000 g pelleted fractions (J. Evans, unpublished 
data). We have also investigated the presence of FLAP in un- 
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Figure 1. Leukotriene production by A23187-stimulated  osteosar- 
coma cells  expressing  5-LO and  FLAP.  Control,  unstimulated 
cells.  A23187, A23187-stimulated  cells.  MK-886,  A23187-stimu- 
lated  cells  preincubated  in the presence of MK-886.  L-583,916, 
A23187-stimulated cells preincubated  in the presence of  L-583,916. 
Cell monolayers were preincubated  with 1/zM MK-886 (C), 1 ttM 
L-583,916 (D) or Me2SO as control (A and B) for 10 rain at 37~ 
and then challenged  with 1 ttM A23187 (B-D) or MeaSO (A) for 
10 min at 37~  The supernatant above the cell monolayer was re- 
moved, and leukotrienes  were extracted  and analyzed by reversed 
phase HPLC as described in Materials  and Methods.  Leukotriene 
products identified by elution position and ultraviolet  spectra were 
6-trans-LTB4, 6-trans-12-epi-LTB4 and LTB4. PGB2 is the internal 
standard. 
Kargman et al. 5-Lipoxygenase  Translocation  in Osteosarcoma  Cells  1703 Figure 2. Immunoblot analysis and photoaifinity labeling of FLAP in osteosarcoma cells. Lane A, immunoblot analysis of FLAP in cells 
expressing 5-LO only, or cells expressing both 5-LO and FLAP. 100,000  g pellet samples (prepared as described in Materials and Methods) 
were combined with SDS sample buffer, and subjected to electrophoresis and immunoblot analysis as described in Materials and Methods. 
Blots were exposed to XAR film for ~24 h. Lane M, 14C-labeled  molecular weight markers (Amersham Corp.). Lane 1, samples from 
osteosarcoma cells expressing 5-LO and FLAP. Lane 2, samples from osteosarcoma ceils expressing 5-LO only. NRS immunoblot was 
incubated with 1:200 dilution of prebleed for H5. H5 immunoblot was incubated with 1:200 dilution of H5. Lane B, photoaffinity labeling 
and immunoprecipitation of FLAP in cells expressing 5-LO only or 5-LO and FLAP, as described in Materials and Methods. Lanes 
1 and 2, samples from osteosarcoma cells expressing 5-LO only. Lanes 3 and 4, samples from osteosarcoma cells expressing 5-LO and 
FLAP. Lanes 1 and 3, labeling in the absence of 1-#M MK-886. Lanes 2 and 4, labeling in the presence of MK-886. 
challenged and A23187-challenged rat PMN and U937 cells 
and found no change in membrane localization after A23187 
localization (Kargman and Reid, unpublished observations). 
Competitive photoaflinity labeling followed by immunopre- 
cipitation  of  membrane-bound  FLAP  confirms  that  os- 
teosarcoma cells expressing 5-LO alone have no detectable 
FLAP and that FLAP expressed in these cells specifically 
binds leukotriene synthesis inhibitors (Fig. 2 B). 
Translocation of  S-LO in Osteosarcoma Cells 
Expressing 5-LO and FLAP 
Previous studies have shown that 5-LO translocates to mem- 
branes in A23187-stimulated human leukocytes, RBL-1 cells, 
rat PMN, Me2SO-differentiated  HL-60 cells; in fMLP-stim- 
ulated Me2SO-differentiated HL-60 cells; and in thapsigar- 
gin-, ionomycin- or antigen-stimulated RBL-2H3 cells (16- 
22, 29). Because FLAP had been shown to be necessary for 
leukotriene production, we questioned whether this protein 
is  also necessary for the translocation of 5-LO.  Osteosar- 
coma cells expressing both 5-LO and FLAP were preincu- 
bated in the absence or presence of 1/~M MK-886 and then 
stimulated with 1/~M A23187, or Me,  SO, as control. After 
the 10-min incubation, the overlaying medium was removed, 
extracted and analyzed by HPLC for leukotriene production, 
the cell monolayer was scraped and 100,000 g supernatants 
and pellets were prepared and analyzed for 5-LO enzyme ac- 
tivity (5-HETE) and 5-LO protein (immunoblot analysis). A 
typical example of one of the immunoblots of 100,000 g su- 
pernatants and pellets in osteosarcoma cells expressing both 
5-LO and FLAP can be seen in Fig. 3. The results of the leu- 
kotriene synthesis and  5-LO translocation and  cytosol to 
membrane fractions in these experiments were quantitated 
and are expressed in Fig. 4. We were unable to detect leu- 
kotrienes  from  unstimulated  cells.  Cells  stimulated  with 
A23187  synthesized  and  secreted  enzymatic and  nonen- 
zymatic isomers of LTB4.  Leukotriene synthesis  in  these 
cells was inhibited when cells were preincubated in the pres- 
ence of MK-886 but not when they were preincubated with 
L-583,916 (Fig. 4  A).  Fig. 4  B demonstrates the A23187- 
stimulation of  cells expressing both 5-LO and FLAP resulted 
in the loss of'~40% of  5-LO enzyme activity from the super- 
natant, consistent with that seen previously in human leuko- 
cytes, and  Me2SO  differentiated HL-60 cells (16-18).  We 
were unable to detect any 5-LO enzyme activity in 100,000 g 
pellets (data not shown). Preincubation of  cells with MK-886 
resulted in ~90% of the 5-LO enzyme activity being main- 
tained in the supernatant.  This was in direct contrast with 
preincubation of cells with L-583,916, which did not lead to 
any recovery of the cytosolic 5-LO enzyme activity (Fig. 
4 B). A similar profile of loss and recovery of immunoreac- 
tive 5-LO protein can be seen in Fig.  4  C.  '~50%  of im- 
munoreactive 5-LO protein is lost from the supernatant of 
A23187-stimulated cells, 70% of which was maintained in 
The Journal of Cell Biology, Volume  119, 1992  1704 Figure 3. A representative immunoblot analysis of 5-LO transloca- 
tion in osteosarcoma cells expressing 5-LO and FLAP. Samples of 
100,000 g supernatants  (100S) and 100,000 g pellets (100P) were 
combined with volume SDS sample buffer, subjected to electro- 
phoresis and transferred to nitrocellulose membranes as described 
in Materials  and  Methods.  Blocked  membranes  were  incubated 
with LO32, a rabbit antibody raised to human leukocyte 5-LO fol- 
lowed by incubation with  [~25I]-protein A (low specific activity). 
Washed membranes were exposed to XAR film for ~24 h.  Lane 
M, molecular weight markers; lanes 1-4, 100S samples; lanes 5-8, 
100P samples; lanes I and 5, samples from control, untreated cells; 
lanes 2 and 6, samples from A23187-treated cells; lanes 3 and 7, 
samples from I-#M MK-886-preincubated,  A23187-treated cells; 
lanes  4  and  8,  samples  from  1-/~M L-583,916-preincubated, 
A23187-treated cells. 
the supernatant when cells were preincubated with MK-886. 
In agreement with the activity analyses, L-583,916 was un- 
able to prevent the loss of any immunoreactive 5-LO protein 
from the  supernatant  after ionophore challenge.  Fig.  4  D 
demonstrates the approximate twofold increase in immuno- 
reactive 5-LO  protein  in  the  pellet of A23187-stimulated 
cells. There was almost complete inhibition of the increase 
of immunoreactive membrane 5-LO protein in A23187-stim- 
ulated cells when cells were preincubated in the presence of 
MK-886.  No inhibition of the  increase of immunoreactive 
membrane 5-LO was seen when cells were preincubated in 
the presence of L-583,916. 
Translocation  of S-LO in Osteosarcoma  Cells 
Expressing 5-LO and Not Expressing FLAP 
To determine whether FLAP was essential for 5-LO translo- 
cation, we performed translocation experiments in osteosar- 
coma cells expressing 5-LO and not expressing FLAE Our 
initial hypothesis was that if FLAP were essential for translo- 
cation, cells lacking the protein would be unable to support 
5-LO  translocation.  Experiments  identical  to  those  per- 
formed with osteosarcoma cells expressing both 5-LO and 
FLAP were performed. A representative example of an im- 
munoblot analysis from osteosarcoma cells expressing 5-LO 
but not FLAP is shown in Fig. 5. In agreement with previous 
findings, we were unable to detect any leukotrienes in cells 
transfected with 5-LO but not FLAP after stimulation with 
A23187 (Fig. 6 A). Surprisingly, the osteosarcoma cells ex- 
pressing 5-LO alone showed a 40 % loss of 5-LO enzyme ac- 
tivity from the supernatant of A23187-treated ceils. As MK- 
886 specifically interacts with FLAP, this compound did not 
inhibit 5 -LO translocation in this system (Fig. 6 B). We were 
unable to detect significant levels of 5-LO enzyme activity 
in pellets of A23187-stimulated cells (data not shown). Con- 
sistent with the 5-LO activity measurements, there was an 
•40  % loss of the immunoreactive 5-LO protein from the su- 
pernatant of A23187-stimulated cells, and preincubation of 
ceils with either MK-886 or L-583,916 was ineffective (Fig. 
6 C). Finally, Fig. 6 D demonstrates the twofold increase in 
immunoreactive 5-LO protein in pellets of A23187-stimu- 
lated cells, and the lack of inhibition of this increase by either 
MK-886 or L-583,916. 
Discussion 
We have used human osteosarcoma cells transfected and ex- 
pressing either 5-LO only or 5-LO as well as FLAP to exam- 
ine the mechanism of A23187-induced  cellular membrane 
association and activation of 5-LO. Wild-type osteosarcoma 
cells express neither 5-LO nor FLAP.  In ceils expressing 
both 5-LO and FLAP,  we have shown that in response to 
A23187  stimulation,  5-LO translocates to membranes and 
leukotrienes are synthesized. A leukotriene synthesis inhibi- 
tor (MK-886) that binds selectively to FLAP inhibits 5-LO 
translocation in these cells. In cells not expressing FLAP, we 
demonstrated that in response to A23187 stimulation, 5-LO 
also associates with membranes although in this case leu- 
kotrienes are not synthesized.  In contrast to osteosarcoma 
cells expressing both 5-LO and FLAP, MK-886 has no effect 
on the 5-LO membrane association in cells not expressing 
FLAP. 
These results  suggest that  A23187-induced  5-LO mem- 
brane association and activation can be separated into at least 
two distinct steps:  (/) movement to the membrane without 
product formation and (2) activation resulting in product for- 
mation. This two-step process is consistent with a recent re- 
port by Coffey et al. who have shown membrane association 
and activation of 5-LO as two distinct and separable events 
in the rat alveolar macrophage (19).  They demonstrated that 
in the resting rat alveolar macrophage, a large proportion of 
the 5-LO enzyme activity and immune recognizable protein 
resides in the membrane fraction. Stimulation of rat alveolar 
macrophage cells with A23187 does not result in a detectable 
increase in 5-LO activity or protein in the membrane frac- 
tion, yet leukotrienes are synthesized. MK-886 inhibits this 
A23187-induced  leukotriene  production.  In  addition,  the 
5-LO associated with membranes in the resting rat alveolar 
macrophage is not dissociated by treatment of cells with MK- 
886 (19).  This is in striking contrast to what has been seen 
in human PMN,  HL-60 cells,  and RBL-2H3 cells,  where 
A23187 stimulation causes a significant shift in the distribu- 
tion of 5-LO from the cytosol to a membrane compartment 
(16-21, 29). In human leukocytes, translocation of 5-LO is 
not only inhibited by MK-886 but MK-886 can also reverse 
5-LO membrane association after ionophore challenge (22). 
This  suggests that  FLAP  binding  compound has  a  direct 
effect on the interaction of 5-LO at a membrane site rather 
than an indirect effect before 5-LO translocation. Studies on 
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Figure  4.  Translocation  of  5-LO  in 
A23187-stimulated  osteosarcoma  cells 
expressing  5-LO  and  FLAE  Lane A, 
leukotriene synthesis. Lane B, 5-LO en- 
zyme activity in 100,000 g supernatants 
(100S). Lane C, immnnoblot analysis of 
5-LO protein in 100,000 g supernatants. 
Lane D,  immnnoblot analysis of 5-LO 
protein in 100,000 g pellets (100P). Cell 
monolayers  were preincubated in  the 
presence or absence of 1/zM MK-886 or 
L-583,916, followed by incubation in the 
presence of 1/aM A23187. The supema- 
tants  above  the  monolayer  were  re- 
moved, extracted, and analyzed for leu- 
kotrienes by reversed phase  HPLC  as 
described  in  Materials  and  Methods. 
100S samples were assayed for 5-LO en- 
zyme activity (B).  100S (C) and 100P 
(D) samples were subjected to immnno- 
blot analysis for 5-LO protein. The rela- 
tive amounts of 5-LO protein were de- 
termined by densitometry. The optical 
density reading  from the scanned auto- 
radiograph is expressed as relative 5-LO 
protein.  The  most  intense  100S  and 
100P signals were arbitrarily  set to 1.0 
and the 100P values were corrected for 
fivefold concentration during  resuspen- 
sion. The values therefore represent the 
relative concentration of 100S and 100P 
5-LO in the cells. Values for leukotriene 
production, 5-LO activity (5-HETE syn- 
thesis), and 5-LO protein represent  the 
mean  +SE  for three  separate experi- 
ments, each performed in duplicate. For 
immunoblot analyses each sample was 
loaded in duplicate. At least nine lanes 
were scanned and their densities aver- 
aged  for each condition,  i.e.,  control, 
A23187,  or A23187  and MK-886.  14C- 
labeled molecular weight marker proteins were loaded on each side of samples to monitor equal transfer of proteins to the nitrocellulose. 
The differences in leukotriene production, 5-LO enzyme activity (5-HETE) and 5-LO protein between unstimulated and A23187-stimulated 
cells, and between A23187 challenge in the absence and presence of MK-886 were statistically significant  as determined by a t test ('P 
<  0.05;  "*P <  0.01; --P <  0.005). 
MK-886 inhibition of leukotriene synthesis in human phago- 
cytes stimulated by A23187, PAF fMLP, C5a, or LTB, sup- 
port this suggestion (30,  31). 
The ability of 5-LO to translocate to membranes  in re- 
sponse to A23187  stimulation in cells  lacking  FLAP  was 
surprising. The observation that preincubation of cells with 
MK-886 had no effect on this membrane association is con- 
sistent with our previous data demonstrating that FLAP is 
the sole selective target of MK-886. Previously, Rouzer and 
Kargman hypothesized translocated 5-LO was inactive due 
to enzyme suicide concomitant with leukotriene synthesis 
(16). When we observed 5-LO associated with membranes 
in osteosarcoma cells  expressing  5-LO alone,  we initially 
predicted that the pelleted enzyme might be active because 
no product was made. However, 5-LO was inactive in mem- 
branes from A23187-stimulated osteosarcoma cells express- 
ing 5-LO alone. Wong et al. have demonstrated that cytosolic 
5-LO is rapidly inactivated by incubation with calcium, ATP 
and arachidonlc acid (29). Also in vitro studies with purified 
recombinant human leukocyte 5-LO have shown the enzyme 
to inactivate in the presence of calcium, membrane and oxy- 
gen (D. Percival, unpublished data). The combination of all 
three components is necessary for inactivation (D. Percival, 
unpublished data).  Therefore,  membrane-associated  5-LO 
in A23187-challenged osteosarcoma cells could be inactive 
due to simultaneous exposure to calcium, membrane and ar- 
achidonic acid. 
Our results with osteosarcoma cells suggest that at least 
the initial membrane association of 5-LO after A23187 stim- 
ulation is the result of an increase in intracellular calcium 
and can be FLAP independent. Wong et al. demonstrate that 
in the broken RBL-1 cell (no stimulation), 5-LO association 
with membranes was calcium concentration dependent over 
the range of 0.05-5 #M (29). They later showed that stimula- 
tion  of  RBL-2H3  cells  with  optimal  concentrations  of 
ionomycin or thapsigargin triggered comparable increases in 
intracellular calcium. Only at intracellular calcium concen- 
trations greater than ~300-400 nM did 5-LO associate with 
membranes and were leukotriene synthesized (20). We have 
recently  shown that HL-60  cell  5-LO  translocates  to the 
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osteosarcoma cells expressing 5-LO only. 100S and 100P samples 
were prepared and analyzed as described in the legend for Fig. 3. 
The identities of the lanes are as follows: lane M, molecular weight 
markers; lanes 1-4, 100S samples; lanes 5-8, 100P samples; lanes 
1 and 5, samples from unstimulated cells; lanes 2 and 6, samples 
from A23187-stimulated  cells; lanes 3 and 7, samples from A23187- 
stimulated cells; preincubated with MK-886 and lanes 4 and 8, sam- 
pies from A23187-stimulated cells preincubated with L-583,916. 
membrane in response to the receptor-mediated stimulus, 
fMLP (18). Although we did not measure the change in intra- 
cellular  calcium  after  stimulation  of  cells  with  fMLP, 
reported studies indicate a maximum intracellular calcium 
concentration of ~o 300  nM  in  fMLP-stimulated ceils  (C. 
Chan,  unpublished data).  The low amount of leukotriene 
production, 5-LO translocation and change in intracellular 
calcium after stimulation of cells with fMLP correlates well 
with results of Wong et al. who show that ~15% of rat RBL- 
2H3 cell 5-LO associated with membranes at intracellular 
calcium concentrations such as those that would be elicited 
by fMLP stimulation (20). Wong et al.  also demonstrated 
that removal of calcium from the medium before stimula- 
tion of rat RBL-2H3 cells with ionomycin or thapsigargin 
eliminated  5-LO  translocation  and  leukotriene  synthesis, 
again implying 5-LO membrane association is calcium de- 
pendent (20). Wong et al. have recently shown that antigen 
stimulation induced •15  % translocation of 5-LO and this 
translocation was inhibited by MK-886 (27). This antigen- 
induced 5-LO-translocation had both a  calcium-dependent 
and calcium-independent component (21). 
Proteins other than 5-LO have been shown to associate 
with membrane in a calcium-dependent fashion. At intracel- 
lular calcium concentrations such as those seen in activated 
cells  (~300  nM),  the  arachidonoyl-hydrolyzing cytosolic 
phospholipase A2 (cPLA2) translocates in vesicular systems 
to  membranes  (32,  33).  Furthermore,  a  140-amino  acid 
fragment of cPLA2 containing a region homologous to the 
constant region 2 of  protein kinase C (PKC C-2) translocates 
to membranes in a calcium-dependent manner (33). Several 
platelet PKC  isoforms have been shown to translocate to 
membranes in the presence of 1 #M PMA (34). Other pro- 
teins with C-2-1ike domains have been found to associate 
with phospholipids, among which are synaptic vesicle pro- 
tein  p65  and  GTPase  activating protein  (GAP)  (35,  36). 
5-LO does not contain a C-2-1ike PKC domain (9). There- 
fore, the membrane association of 5-LO appears to differ 
from that of cPLA2 and other C-2-containing proteins. 
It is important to note that although our results with os- 
teosarcoma cells suggest that 5-LO membrane association 
can occur in the absence of FLAP, we are unaware of any 
normal cell type in  which 5-LO exists in the absence of 
FLAP. In all cells (except alveolar macrophage) in which 
5-LO translocation has  been investigated (human and  rat 
PMN, RBL-1, RBL-2H3, and HL-60 ceils) MK-886 has in- 
hibited both translocation of 5-LO and leukotriene synthesis. 
Therefore, 5-LO membrane movement may in the majority 
of cell types expressing 5-LO be modulated by the presence 
of both calcium and FLAP. It is clear that the rat alveolar 
macrophage is an exception to this rule and the initial associ- 
ation of 5-LO to membranes in this cell type appears to be 
FLAP independent (19). Nevertheless, Coffey et al. demon- 
strate that leukotriene synthesis is inhibited by MK-886 in 
the A23187-stimulated rat alveolar macrophage, consistent 
with our results that leukotriene synthesis is dependent on an 
interaction between 5-LO and FLAP (19). 
As a result of our studies, we propose a number of models 
to explain 5-LO translocation to membranes in intact cells 
in  the  presence or absence of FLAP.  These models  also 
visualize how MK-886 binding to FLAP may prevent 5-LO 
membrane association. The models are depicted in Fig. 7. 
A 5-LO membrane binding site (MBS) may be comprised of 
a  number of proteins involved in the leukotriene synthetic 
pathway.  The membrane binding  site may be  exclusively 
lipid. In cells lacking FLAP (Fig. 7 A), an increase in intra- 
cellular calcium after A23187 activation facilitates the as- 
sociation of 5-LO with the MBS. Calcium may alter the con- 
formation or aggregation state of 5-LO itself and thereby 
facilitate membrane association. Because FLAP is essential 
for leukotriene synthesis leukotrienes are not synthesized in 
the absence of FLAP expression (Fig. 7 A). Preincubation 
of these ceils in the presence of MK-886 has no effect on the 
membrane association of 5-LO as MK-886 specifically binds 
to FLAP. Hence, 5-LO translocation can be considered cal- 
cium dependent and FLAP independent. In cells expressing 
FLAP (Fig. 7 B), an increase in intracellular calcium after 
A23187 activation also facilitates the association of 5-LO 
with the membrane. However, in this case, leukotrienes are 
synthesized because FLAP is present in these cells. The ex- 
act way in which FLAP activates leukotriene synthesis is un- 
clear but it is possible FLAP facilitates the transfer of  arachi- 
donic acid or 5-HPETE to 5-LO. In whole cells, in contrast 
to broken cell assays,  production of leukotrienes relative to 
5-Hete is enhanced, so FLAP may alter the conformation of 
5-LO to facilitate the concerted oxidation and dehydration 
reactions.  Fig.  7  C  portrays a  cell containing FLAP and 
preincubated in the presence of MK-886.  In Fig.  7  C, the 
membrane binding site at which 5-LO interacts has under- 
gone a conformational change after binding of MK-886 to 
FLAP. 5-LO is unable to interact with the altered membrane 
site; it remains in the cytosol and is unable to interact with 
its  substrate  arachidonic acid.  Consequently, leukotrienes 
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Figure  6.  Translocation  of  5-LO  in 
A23187-stimulated  osteosarcoma  cells 
expressing 5-LO only.  Lane A, leuko- 
triene synthesis. Lane B, 5-LO enzyme 
activity in 100,000 g supernatants. Lane 
C,  immunoblot  of  5-LO  protein  in 
100,000  g  supernatants.  Lane  D,  im- 
munoblot analysis of 5-LO protein in 
100,000 g pellets. Cell monolayers were 
preincubated in the presence or absence 
of 1 #M  MK-886 or  1 /~M L-583,916 
and then incubated in the presence or 
absence of 1/zM A23187.  The superna- 
tant above the monolayer was removed, 
extracted and leukotriene  production (A) 
analyzed by reversed phase HPLC as de- 
scribed in Materials and Methods. 100S 
samples were analyzed for 5-LO enzyme 
activity (B) and 5-LO protein by immu- 
noblot analysis (C). 100P samples were 
also analyzed for 5-LO protein by im- 
munoblot  analysis  (D).  The  relative 
amounts  of 5-LO  protein were  deter- 
mined by densitometry  and are  expressed 
as described in the legend for Fig. 4. 
Values for leukotriene  production, 5-LO 
enzyme activity  and 5-LO protein repre- 
sent the mean :i:SE for two separate ex- 
periments each performed in duplicate. 
For immunoblot analyses, each sample 
was  loaded  in  duplicate.  At  least  six 
lanes were scanned and their densities 
averaged for each condition, i.e., con- 
trol, A23187,  or A23187 and MK-886. 
14C-labeled  molecular  weight  marker 
proteins  were  loaded on  each  side of 
samples  to  monitor  equal  transfer  of 
proteins to the nitrocellulose. The dif- 
ferences in leukotriene production, 5-LO 
enzyme activity and 5-LO protein be- 
tween unstimulated and A2.3187-stimu- 
lated samples were statistically signifi- 
cant  as  determined  by  a  t  test  (***P 
<  0.002). 
Figure 7. Models for A23187-induced translocation of 5-LO. A hy- 
pothetical membrane binding site (MBS) may be a multienzyme 
complex containing proteins in the leukotriene synthetic pathway 
or may be lipid only. Lane a, upon A23187 stimulation, a rise in 
intracellular calcium results in the membrane association of 5-LO. 
This may be due to a conformational change in 5-LO or a change 
in 5-LO aggregation state. Because FLAP is absent, leukotrienes 
are not synthesized. Lane B, upon A23187 stimulation, a rise in 
intracellular calcium results in the membrane association of 5-LO; 
"activation"  of 5-LO  by  FLAP results in  the  formation of leu- 
kotrienes. Lane C, preincubation of cells expressing FLAP with 
MK-886 leads to high affinity binding of MK-886 to FLAP; this 
results in a conformational change in the membrane binding site at 
which 5-LO interacts. This alteration in 5-LO binding site may be 
induced by a conformational change in FLAP itself. After A23187 
stimulation, despite increased calcium concentrations, 5-LO is un- 
able to interact with its membrane binding site and the synthesis 
of leukotrienes is effectively inhibited. Lanes D-F portray a model 
in which there is a direct interaction between 5-LO and FLAP. Lane 
D, after A23187 stimulation 5-LO binds to the MBS. Lane E, after 
A23187 stimulation, a direct interaction of 5-LO and FLAP occurs 
at the MBS resulting in the formation of leukotrienes. Lane F, MK- 
886 binds to FLAP and prevents 5-LO membrane association via 
steric inhibition blocking a  direct protein-protein interaction of 
5-LO and FLAP. are not synthesized.  This model implies that a conforma- 
tional change resulting from binding of MK-886  to FLAP 
may prevent  5-LO membrane association.  The conforrna- 
tional change in the membrane binding site for 5-LO may be 
induced by a conformational change in FLAP itself.  This 
model  does  not require a  direct association  of 5-LO  and 
FLAP.  The model  shown in Fig.  7  D-F predicts a direct 
protein-protein association of 5-LO and FLAP.  Binding of 
MK-886 to FLAP may prevent 5-LO membrane association 
by way of steric inhibition as depicted in Fig. 7 E  Because 
MK-886  is  relatively  small  in  comparison  to  5-LO  and 
FLAP, steric inhibition would be more probable if 5-LO and 
FLAP directly interact.  However, to date we have not been 
able to show direct interaction of 5-LO and FLAP (S. Karg- 
man, P. Vickers, and D. K. Miller, unpublished data). D-F 
shows 5-LO binding at two sites, one of which can be a direct 
interaction  with  FLAP.  Whether  5-LO  binds  directly  to 
FLAP and if so if it is the same site at which MK-886 binds 
is unclear.  We are currently  investigating  these possibilities 
by site-specific and deletion mutagenesis analysis of FLAP 
in several recombinant expression systems. Both models pre- 
dict  5-LO  association  at  the  same  cellular  membrane  as 
FLAP. We are currently  addressing this prediction by elec- 
tron micrographic immunohistochemical localization stud- 
ies on 5-LO and FLAP. 
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